<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02593838</url>
  </required_header>
  <id_info>
    <org_study_id>USZ-2015-0393</org_study_id>
    <nct_id>NCT02593838</nct_id>
  </id_info>
  <brief_title>Dynamic CT Myocardial Perfusion Imaging</brief_title>
  <official_title>Diagnostic Value and Practicability of Dynamic CT Stress and Rest Myocardial Perfusion Imaging in Daily Clinical Practice - A Monocentric Prospective Diagnostic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at evaluating the feasibility of CT myocardial perfusion imaging in daily
      clinical practice and compare it to SPECT perfusion imaging in order to assess sensitivity
      and specifity of CT myocardial perfusion imaging compared to SPECT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If after the clinically indicated CCTA a myocardial perfusion examination is indicated, first
      a single ultra low dose CT scan will be performed to look for late enhancement of potentially
      scarred myocardium. Together with the contrast agent co-injection of the clinically indicated
      tracer 99mTc-Tetrofosmin will be performed for later scintigraphic perfusion evaluation.
      After stress perfusion imaging CT rest perfusion imaging will be performed in a similar
      fashion. After acquisition of CT rest perfusion images scintigraphic stress and rest image
      acquisition will be performed as in daily clinical routine with an additional administration
      of 99mTc-Tetrofosmin resting dose if necessary.

      CT stress and rest perfusion will be compared to the clinically indicated and well
      established SPECT examination.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of CT-MPI against SPECT-MPI</measure>
    <time_frame>2 years</time_frame>
    <description>Sensitivity and specificity of CT-MPI to diagnose obstructive coronary artery disease using SPECTR-MPI as the standard reference</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parameters influencing image quality of CT-MPI - Body physique</measure>
    <time_frame>2 years</time_frame>
    <description>Correlation between visually assessed image quality of CT-MPI and patient's body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parameters influencing image quality of CT-MPI - Heart rate</measure>
    <time_frame>2 years</time_frame>
    <description>Correlation between visually assessed image quality of CT-MPI and patient's heart rate during the scan</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>CTP and SPECT-MPI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Every patient enrolled will undergo CT-MPI and SPECT-MPI. The latter is clinically indicated,.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT-MPI and SPECT-MPI</intervention_name>
    <description>All patients undergo CT-MPI plus SPECT-MPI</description>
    <arm_group_label>CTP and SPECT-MPI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Referral for cardiac hybrid imaging with CCTA and SPECT

          -  Male and Female subjects 18 years of age or older,

          -  Written informed consent by the participant after information about the project

        Exclusion Criteria:

          -  Contraindications for CCTA (including renal failure with a GFR &lt;60ml/min/1.73m2,
             allergies to ionidated constrast agents)

          -  Inability to follow the examination procedure due to language barriers, mental
             disease, dementia etc.

          -  Pregnancy or breast feeding

          -  Known allergies to iodinated contrast agent (Visipaque 速), 99mTc-Tetrofosmin (Myoview
             速), betablockers (Beloc i.v. 速) or nitrates (Isoket -Spray速)

          -  Hypersensitivity to adenosine

          -  Asthma bronchiale
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronny R Buechel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Department of Nuclear Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ronny R Buechel, MD</last_name>
    <phone>0044442551059</phone>
    <email>ronny.buechel@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Valerie Treyer, PhD</last_name>
    <phone>0044442551111</phone>
    <email>valerie.treyer@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nuclear Medicine, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Treyer, PhD</last_name>
      <email>valerie.treyer@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ronny R Buechel, MD</last_name>
      <phone>+41 44 255 10 59</phone>
      <email>ronny.buechel@usz.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Ronny R Buechel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2015</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

